The present invention relates to a benzazepinone compound represented by the following formula (I):wherein R1 represents a C1-C6 alkyl group or halogeno C1-C6 alkyl group, R2 represents a carboxyl group which may be protected, and Y represents a group represented by the formula (II):wherein Z represents CH or a nitrogen atom,or a pharmaceutically acceptable salt thereof.